Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Eric Oliver

Allergy & Immunology Baltimore, MD Medical Doctor

NPI 1912168113 CMS profile 1298151

5501 Hopkins Bayview Circle, Baltimore, MD 21224

Open in the dashboard

General payments

$31,183

81 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$524 paid to institutions, not to them · program year 2025

Through program year 2025, Eric Oliver of Baltimore, MD is reported in the CMS Open Payments database as having received $31,183 across 81 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $524 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 91st percentile of Allergy & Immunology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $5,019 7
2023 General $15,921 20
2020 General $8,400 2
2019 General $1,843 52

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Eric Oliver
  • Allergy & Immunology median
  • Middle half of Allergy & Immunology
  • National median

In program year 2025, general payments to Eric Oliver were reported at $5,019. Among 336 Allergy & Immunology profiles paid that year, the median was $682 and the middle half received between $143 and $2,317.

Show as a table
Year Eric Oliver Allergy & Immunology median Middle half National median
2019 $1,843 $378 $115–$1,178 $163
2020 $8,400 $303 $75–$1,581 $114
2021 $0 $407 $122–$1,475 $132
2022 $0 $357 $120–$1,340 $149
2023 $15,921 $445 $124–$1,536 $160
2024 $0 $541 $129–$1,763 $164
2025 $5,019 $682 $143–$2,317 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Novartis Pharmaceuticals Corporation $11,576 12 payments
  2. Regeneron Healthcare Solutions, Inc. $9,311 14 payments
  3. Eli Lilly Export S.A. Puerto Rico Branch $8,400 2 payments
  4. Eli Lilly and Company $1,843 52 payments
  5. Sanofi-Aventis U.S. LLC $53 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $25,850 7 payments
  2. Travel and Lodging $3,515 23 payments
  3. Food and Beverage $1,765 50 payments
  4. Education $53 1 payment
Products named General payments · program years 2019–2025
  1. DUPIXENT Inflammation And Immunology $9,311 14 payments
  2. Rhapsido $883 4 payments
  3. DUPIXENT Immunology $53 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 10 billing codes

Paid by Medicare

$5,164

Medicare's payments for the services billed

Medicare patients

26

Average age 61

Services billed

66

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 65%
Arthritis 54%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

81 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Allergy & Immunology in Maryland

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record